2026 ICD-10-CM Diagnosis Code P94.0Transient neonatal myasthenia gravis
ICD-10-CM Codes›P00–P96›P90-P96›P94
- Billable — Valid for Submission
- Not Chronic
P94.0 is a billable ICD-10-CM diagnosis code for transient neonatal myasthenia gravis. It is valid on HIPAA claims for fiscal year 2026 (October 1, 2025 through September 30, 2026). Coders also document this condition as myasthenia gravis. In AHRQ's Clinical Classifications Software (CCSR), this diagnosis falls under Other specified and unspecified perinatal conditions.
Code Identity
Code Classification
Approximate SynonymsGuidance
Alternate terms and clinical phrases that map to this code.
- Myasthenia gravis
- Neonatal myasthenia gravis
- Neonatal neuromuscular disorder
- Transient neonatal myasthenia gravis
Tabular List NotesGuidance
Coding notes and annotation back-references applicable to this code.
Type 1 Excludes
- myasthenia gravis G70.0
A type 1 excludes note is a pure excludes note. It means "NOT CODED HERE!" An Excludes1 note indicates that the code excluded should never be used at the same time as the code above the Excludes1 note. An Excludes1 is used when two conditions cannot occur together, such as a congenital form versus an acquired form of the same condition.
Index to Diseases and InjuriesGuidance
Alphabetical index entries that point to this code.
- Myasthenia - G70.9
- neonatal, transient - P94.0
External Cause of Injuries IndexGuidance
References for this code in the External Cause of Injuries Index.
- Myasthenia
- gravis
- neonatal, transient
Clinical ClassificationClinical
AHRQ’s CCSR groups this code into broader clinical categories.
Clinical InformationClinical
Myasthenia Gravis
a disorder of neuromuscular transmission characterized by fatigable weakness of cranial and skeletal muscles with elevated titers of acetylcholine receptors or muscle-specific receptor tyrosine kinase (musk) autoantibodies. clinical manifestations may include ocular muscle weakness (fluctuating, asymmetric, external ophthalmoplegia; diplopia; ptosis; and weakness of eye closure) and extraocular fatigable weakness of facial, bulbar, respiratory, and proximal limb muscles. the disease may remain limited to the ocular muscles (ocular myasthenia). thymoma is commonly associated with this condition.Myasthenia Gravis, Autoimmune, Experimental
any autoimmune animal disease model used in the study of myasthenia gravis. injection with purified neuromuscular junction acetylcholine receptor (achr) (see receptors, cholinergic) components results in a myasthenic syndrome that has acute and chronic phases. the motor endplate pathology, loss of acetylcholine receptors, presence of circulating anti-achr antibodies, and electrophysiologic changes make this condition virtually identical to human myasthenia gravis. passive transfer of achr antibodies or lymphocytes from afflicted animals to normals induces passive transfer experimental autoimmune myasthenia gravis. (from joynt, clinical neurology, 1997, ch 54, p3)Myasthenia Gravis, Neonatal
a disorder of neuromuscular transmission that occurs in a minority of newborns born to women with myasthenia gravis. clinical features are usually present at birth or develop in the first 3 days of life and consist of hypotonia and impaired respiratory, suck, and swallowing abilities. this condition is associated with the passive transfer of acetylcholine receptor antibodies through the placenta. in the majority of infants the myasthenic weakness resolves (i.e., transient neonatal myasthenia gravis) although this disorder may rarely continue beyond the neonatal period (i.e., persistent neonatal myasthenia gravis). (from menkes, textbook of child neurology, 5th ed, p823; neurology 1997 jan;48(1):50-4)Myasthenic Syndromes, Congenital
a heterogeneous group of disorders characterized by a congenital defect in neuromuscular transmission at the neuromuscular junction. this includes presynaptic, synaptic, and postsynaptic disorders (that are not of autoimmune origin). the majority of these diseases are caused by mutations of various subunits of the nicotinic acetylcholine receptor (receptors, nicotinic) on the postsynaptic surface of the junction. (from arch neurol 1999 feb;56(2):163-7)Transient Neonatal Myasthenia Gravis
a condition characterized as a temporary autoimmune neuromuscular disease leading to fluctuating muscle weakness and fatigue in a newborn infant.
Patient EducationClinical
Myasthenia Gravis
Myasthenia gravis, sometimes called MG, is a chronic (long-lasting) disease that causes weakness in your voluntary muscles. The voluntary muscles are the ones that you can control. They include the muscles you use for:
The full article covers:
- What is myasthenia gravis?
- What causes myasthenia gravis?
- Who is more likely to develop myasthenia gravis?
- What are the symptoms of myasthenia gravis?
- How is myasthenia gravis diagnosed?
- What are the treatments for myasthenia gravis?
Read the full article at MedlinePlus
Courtesy of MedlinePlus, a service of the U.S. National Library of Medicine.
Convert P94.0 to ICD-9-CMHistory
The closest ICD-9-CM equivalents under the General Equivalence Mappings.
Code HistoryHistory
Questions About P94.0Overview
Is P94.0 (Disorders of muscle tone of newborn) a billable code?
Yes. This is a billable ICD-10-CM code, specific enough to report transient neonatal myasthenia gravis on HIPAA-covered claims from October 1, 2025 through September 30, 2026.
What is the ICD-9 equivalent of P94.0?
Under the General Equivalence Mappings, transient neonatal myasthenia gravis converts to ICD-9-CM 775.2 (neonat myasthenia gravis). The mapping is approximate, so confirm the match fits the documentation.
Footnotes
[1] Not chronic - A diagnosis code that does not fit the criteria for chronic condition (duration, ongoing medical treatment, and limitations) is considered not chronic. Some codes designated as not chronic are acute conditions. Other diagnosis codes that indicate a possible chronic condition, but for which the duration of the illness is not specified in the code description (i.e., we do not know the condition has lasted 12 months or longer) also are considered not chronic.
